Home › Funds › Bleichroeder LP › MAIA

Bleichroeder LP position in MAIA

MAIA BIOTECHNOLOGY INC · Health Care

Bleichroeder LP reported holding 500,000 shares of MAIA (MAIA BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$720K, representing 0.13% of its reported portfolio and ranking #49 among its reported holdings. Bleichroeder LP has disclosed MAIA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)500.00K sh
Reported value held$720.00K
Portfolio Weight0.13%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's MAIA position evolved

Bleichroeder LP first disclosed a stake in MAIA in Q1 2026 at 500,000 shares (US$700K). The position peaked in Q2 2026 at 500,000 shares, worth US$720K. Across 2 filings, Bleichroeder LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 500,000 shares valued at US$720K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 500.00K $700.00K New
Q2 2026 500.00K $720.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MAIA and 13F data

MAIA (MAIA BIOTECHNOLOGY INC) is a Health Care company. 37 other funds we track also report a position in MAIA — the largest reported positions include Solas Capital Management, LLC (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MAIA

All MAIA fund holders →

FAQ

How long has Bleichroeder LP held MAIA?

Bleichroeder LP has disclosed MAIA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Bleichroeder LP's current position in MAIA?

As of Q2 2026, Bleichroeder LP holds 500.00K shares of MAIA (MAIA BIOTECHNOLOGY INC), valued at $720.00K, representing 0.13% of its reported portfolio and ranking #49.

Has Bleichroeder LP been buying or selling MAIA?

In the latest 13F filing (Q2 2026), Bleichroeder LP held unchanged its position in MAIA. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold MAIA?

Other major institutional holders of MAIA include Solas Capital Management, LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.